FdaApplication
NDA 022350
Identifiers
- fda_app_no: NDA022350
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA AB |
| application_type | NDA |
| approval_date | 2009-07-31 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
2 products